Kraken now accepts ten tokenized stocks and ETFs as collateral for futures and margin trading, with haircuts of 10-30% and ...
Novartis said it agreed to pay up to $1.5 billion for Myricx Bio, in a bid to bolster its portfolio amid industry competition for oncology drugs. The Swiss pharmaceutical company said it would ...
Novartis said it agreed to pay up to $1.5 billion for Myricx Bio to bolster its oncology capabilities. The Swiss pharmaceutical company said it would purchase the privately held U.K.-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results